127 related articles for article (PubMed ID: 4013136)
21. [Management with antithrombin III concentrate in a pregnant woman with hereditary antithrombin III deficiency].
Higuchi M; Konya H; Tanaka H; Masuda H; Nishida Y; Koyama T; Suehiro A; Kakishita E; Ishita K
Rinsho Ketsueki; 1990 Sep; 31(9):1544-7. PubMed ID: 2246830
[TBL] [Abstract][Full Text] [Related]
22. [Isolation and characteristics of antithrombin III from human plasma].
Markova OA; Kalashnikov VV; Khvatov VB
Vopr Med Khim; 1987; 33(3):62-6. PubMed ID: 3630019
[TBL] [Abstract][Full Text] [Related]
23. Properties and catabolism of heat treated antithrombin III concentrate.
Tengborn L; Frohm B; Nilsson LE; Johansson L; Andersson LO
Thromb Res; 1987 Dec; 48(6):701-11. PubMed ID: 3433260
[TBL] [Abstract][Full Text] [Related]
24. An improved method for removal of antithrombin III from post-heparin plasma lipase fractions with a high recovery rate.
Moriguchi EH; Tamachi H; Homma Y; Goto Y
Tokai J Exp Clin Med; 1991 Mar; 16(1):33-41. PubMed ID: 1780907
[TBL] [Abstract][Full Text] [Related]
25. [Anti-coagulant therapy--antithrombin III].
Tsuji H
Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
[TBL] [Abstract][Full Text] [Related]
26. [Properties and virus safety of a pasteurized antithrombin III concentrate].
Karges HE; Fuhge P; Heimburger N
Arzneimittelforschung; 1987 Jul; 37(7):756-8. PubMed ID: 2823838
[TBL] [Abstract][Full Text] [Related]
27. Treatment of consumption coagulopathy with antithrombin concentrate in children with acquired antithrombin deficiency--a feasibility pilot study.
Kreuz WD; Schneider W; Nowak-Göttl U
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S187-91. PubMed ID: 10650867
[TBL] [Abstract][Full Text] [Related]
28. The antithrombin III content of cryoprecipitate prepared from blood collected with and without heparin.
Cosgriff TM; Hodgson LA; West JV
Vox Sang; 1983; 44(2):98-101. PubMed ID: 6402859
[TBL] [Abstract][Full Text] [Related]
29. Preparation of three types of heparin-sepharose and their binding activities to thrombin and antithrombin III.
Funahashi M; Matsumoto I; Seno N
Anal Biochem; 1982 Nov; 126(2):414-21. PubMed ID: 7158775
[No Abstract] [Full Text] [Related]
30. Separation of active and inactive forms of human antithrombin by heparin affinity chromatography.
Heger A; Grunert T; Schulz P; Josic D; Buchacher A
Thromb Res; 2002 Apr; 106(2):157-64. PubMed ID: 12182916
[TBL] [Abstract][Full Text] [Related]
31. Effective prophylaxis of thrombosis by antithrombin III concentrate in a pregnant woman with congenital antithrombin III deficiency: relations between plasma antithrombin III activity and the plasma levels of hemostatic molecular markers.
Inomoto T; Takamoto M; Tamura R; Maegawa M; Kamada M; Takayanagi M
Haemostasis; 1991; 21(3):147-54. PubMed ID: 1773985
[TBL] [Abstract][Full Text] [Related]
32. Distinction of two pathologic antithrombin III molecules: antithrombin III "Aalborg' and antithrombin III "Budapest'.
Sørensen PJ; Sas G; Petó I; Blaskó G; Kremmer T; Samu A
Thromb Res; 1982 May; 26(3):211-9. PubMed ID: 7112514
[TBL] [Abstract][Full Text] [Related]
33. Inactivation of HIV in antithrombin-III concentrate by pasteurization.
Piszkiewicz D; Apfelzweig R; Bourret L; Hattley K; Cabradilla CD; McDougal JS; Menache D
Transfusion; 1988; 28(2):198-9. PubMed ID: 3354052
[No Abstract] [Full Text] [Related]
34. Antithrombin III Northwick Park: demonstration of an inactive high MW complex with increased affinity for heparin.
Lane DA; Flynn A; Ireland H; Erdjument H; Samson D; Howarth D; Thompson E
Br J Haematol; 1987 Apr; 65(4):451-6. PubMed ID: 3580302
[TBL] [Abstract][Full Text] [Related]
35. Comparison of membrane adsorber (MA) based purification schemes for the down-stream processing of recombinant h-AT III.
Reif OW; Freitag R
Bioseparation; 1994 Dec; 4(6):369-81. PubMed ID: 7765681
[TBL] [Abstract][Full Text] [Related]
36. Heparin cofactor II: purification and antibody production.
Tran TH; Lämmle B; Zbinden B; Duckert F
Thromb Haemost; 1986 Feb; 55(1):19-23. PubMed ID: 3518132
[TBL] [Abstract][Full Text] [Related]
37. Severe antithrombin III deficiency in a patient with pre-eclampsia. Observations on the effect of human AT III concentrate transfusion.
Büller HR; Weenink AH; Treffers PE; Kahlé LH; Otten HA; ten Cate JW
Scand J Haematol; 1980 Jul; 25(1):81-6. PubMed ID: 7444377
[TBL] [Abstract][Full Text] [Related]
38. Phosphotungstate as a useful eluent for antithrombin III purification by heparin-agarose affinity chromatography.
Tajima Y; Shizuka R; Oshitani S; Amagai H
Thromb Res; 1990 Mar; 57(5):697-704. PubMed ID: 2339364
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic antithrombin III administration during pregnancy immediately reduces the thrombin hyperactivity of congenital antithrombin III deficiency by forming thrombin-antithrombin III complexes.
Kario K; Matsuo T; Kodama K; Matsuo M
Thromb Res; 1992 Jun; 66(5):509-15. PubMed ID: 1523607
[TBL] [Abstract][Full Text] [Related]
40. Uses of antithrombin III concentrate in congenital and acquired deficiency states.
Bucur SZ; Levy JH; Despotis GJ; Spiess BD; Hillyer CD
Transfusion; 1998 May; 38(5):481-98. PubMed ID: 9633563
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
